Cargando…
Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer
Acquired cisplatin resistance in cervical cancer therapy is principally caused by reduction in intracellular drug accumulation, which is exerted by hyperactivation of the oncogenic PI3K/Akt signaling axis and overexpression of cisplatin-exporter MRP2 along with prosurvival effectors NF-κB and IAPs i...
Autores principales: | Mahapatra, Elizabeth, Sengupta, Debomita, Kumar, Ravindra, Dehury, Budheswar, Das, Salini, Roy, Madhumita, Mukherjee, Sutapa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081374/ https://www.ncbi.nlm.nih.gov/pubmed/35548339 http://dx.doi.org/10.3389/fphar.2022.803114 |
Ejemplares similares
-
Aspirin Restores Radiosensitivity in Cervical Cancer Cells by Inducing Mitotic Catastrophe through Downregulating G2/M Effectors
por: Das, Salini, et al.
Publicado: (2022) -
PEITC: A resounding molecule averts metastasis in breast cancer cells in vitro by regulating PKCδ/Aurora A interplay
por: Biswas, Souvick, et al.
Publicado: (2022) -
Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells
por: Biswas, Souvick, et al.
Publicado: (2021) -
Dietary phenethylisothiocyanate attenuates bowel inflammation in mice
por: Dey, Moul, et al.
Publicado: (2010) -
Phenethylisothiocyanate Alters Site- and Promoter-Specific Histone Tail Modifications in Cancer Cells
por: Liu, Yi, et al.
Publicado: (2013)